Clinical trial
BioNIR Ridaforolimus Eluting Coronary Stent System (BioNIR) In Coronary Stenosis Trial
NCT02834806 is registered in ClinicalTrials.gov with Medinol Ltd. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- BioNIR Ridaforolimus Eluting Coronary Stent System (BioNIR) In Coronary Stenosis Trial
- Lead sponsor
- Medinol Ltd.
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- September 30, 2016
- Completion date
- December 16, 2017
- Enrollment
- 58 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
stenosis